Citation

Ye L, Shipley E, Lippmann S. Am. J. Health Syst. Pharm. 2019; 76(8): 487-488.

Affiliation

Department of Psychiatry University of Louisville School of Medicine Louisville, KY.

Copyright

(Copyright © 2019, American Society of Health-System Pharmacists)

DOI

10.1093/ajhp/zxz021

PMID

31361867

Abstract

Bullying refers to aggressive behavior that is usually repetitive and intentional, in which a power differential exists between the victim and bully.1 Approximately 30% of children are bullied at school. Symptoms of posttraumatic stress disorder (PTSD) in youths resulting from school bullying are found in a range of between 27% and 40% of cases.2 Sequelae from bullying at school also include anxiety, depression, and suicidality.1-3

The optimal management of PTSD symptoms linked to school bullying remains unclear. Trauma-focused cognitive behavior therapies are usually the first intervention for youths with PTSD. Selective serotonin reuptake inhibitors...

© American Society of Health-System Pharmacists 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Language: en

Keywords

ADHD; PTSD; anxiety disorder; mood disorder; pharmacotherapy; school bullying; transdermal clonidine